Everything you need to know about TMS Advocacy: How Organizations Are Working to Expand Access and Insurance Coverage — how it works, what it costs, and how to find a provider who actually knows what they're doing.

Transcranial magnetic stimulation has been FDA-cleared for major depressive disorder since 2008, yet millions of Americans who could benefit still cannot access treatment. Insurance coverage remains inconsistent, many plans impose restrictive treatment-resistant criteria, and Medicare coverage is limited. A growing movement of advocates, healthcare providers, and organizations is working to change this reality. Understanding the landscape of TMS advocacy can help patients become informed participants in expanding access.

What You’ll Learn

• Why insurance coverage for TMS remains inconsistent despite FDA clearance
• Key TMS advocacy organizations and their priorities
• Mental health parity requirements and how they apply to TMS
• State and federal legislative efforts expanding TMS access
• Practical strategies for getting your TMS coverage approved

Why TMS Coverage Remains Limited

Despite robust clinical evidence, TMS faces several structural barriers to widespread coverage:

Insurance market fragmentation — Different insurers apply different criteria, creating a patchwork of coverage that leaves many patients without access.

Restrictive coverage policies — Many insurers require failure of 4+ antidepressant medications before covering TMS, despite evidence that earlier intervention is more effective.

Cost concerns — A full TMS treatment course can cost $6,000-15,000 without insurance, creating barriers for uninsured and underinsured patients.

Limited provider networks — TMS requires specialized equipment and trained clinicians, limiting availability, particularly in rural areas.

Medicare limitations — CMS coverage for TMS is restricted, and local coverage determinations vary by region.

Key TMS Advocacy Organizations

Clinical TMS Society (CTMSS)

The Clinical TMS Society represents over 500 TMS providers and researchers worldwide. Their advocacy priorities include:

• Promoting evidence-based TMS protocols
• Advocating for expanded insurance coverage
• Developing treatment guidelines and provider standards
• Supporting research and training initiatives

The CTMSS has published consensus guidelines on TMS treatment and has engaged with payers and policymakers on coverage issues.

American Psychiatric Association (APA)

The APA, with over 38,000 members, has recognized TMS as an evidence-based treatment. The organization advocates for:

• Mental health parity in insurance coverage
• Adequate reimbursement for TMS procedures
• Increased access to neuromodulation treatments

Brain Stimulation Advocacy Network (BSAN)

The BSAN focuses specifically on advancing policies that support access to brain stimulation therapies including TMS, ECT, and emerging neuromodulation approaches. Their efforts include:

• Congressional education on neuromodulation
• Coalition building among patient and provider groups
• Monitoring federal and state policy developments

National Alliance on Mental Illness (NAMI)

As the nation’s largest mental health organization, NAMI advocates broadly for mental health access and parity. While not TMS-specific, NAMI’s support for:

• Mental health insurance parity
• Increased access to treatments
• Reduced stigma around mental illness

…creates a favorable environment for TMS coverage advocacy.

Legislative Efforts

Mental Health Parity Requirements

The Mental Health Parity and Addiction Equity Act (MHPAEA) requires most health plans to provide coverage for mental health services that is comparable to medical/surgical coverage. Advocates argue that insurers’ restrictive TMS coverage policies may violate parity requirements by imposing more burdensome criteria than for comparable medical treatments.

Recent parity enforcement efforts have focused on:

• Step therapy restrictions
• Prior authorization requirements
• Geographic and network limitations
• Quantitative and non-quantitative treatment limitations

State-Level Initiatives

Several states have passed or are considering legislation to improve TMS access:

Coverage mandates — A small number of states have considered or passed laws requiring TMS coverage, though such mandates face opposition from insurers and employers.

Step therapy reform — Many states have passed laws limiting step therapy requirements, which could help patients access TMS sooner.

Prior authorization reform — Efforts to streamline or eliminate prior authorization for evidence-based treatments are ongoing in multiple states.

Federal Advocacy

At the federal level, advocacy priorities include:

• Medicare coverage expansion for TMS -TRICARE coverage for military beneficiaries
• VA access to TMS for veterans with depression and PTSD
• Support for CMS guidance promoting consistent TMS coverage

Insurance Coverage Strategies

While advocacy works to improve coverage long-term, patients can employ strategies to obtain coverage now:

Understanding Your Plan

1. Review your specific policy for TMS coverage language
2. Identify coverage criteria — how many medication failures are required?
3. Check for prior authorization requirements — what documentation is needed?
4. Look for out-of-network benefits — can you receive care from an out-of-network TMS provider?
5. Ask about appeals processes — what is the process if coverage is denied?

Tips for Getting Coverage

Document treatment history thoroughly — Records of all medication trials, including doses and durations, are essential.

Get supporting letters from providers — Psychiatrists and neurologists can advocate for medical necessity.

Cite clinical guidelines — Reference published evidence and professional society recommendations.

Request peer-to-peer review — Ask your provider to speak directly with the insurer’s medical director.

File appeals promptly — Know your appeal deadlines and follow them exactly.

How Patients Can Get Involved

Share Your Story

Personal narratives are powerful advocacy tools. Consider:

• Writing to your congressional representatives about TMS access
• Participating in patient advocacy organizations
• Sharing your experience with media or policymakers
• Joining online communities to connect with other TMS advocates

Support Advocacy Organizations

Financial and volunteer support for advocacy groups amplifies their impact:

• Join organizations like NAMI, APA, or CTMSS
• Participate in advocacy days or fly-ins
• Contribute to political action committees supporting mental health
• Volunteer to review policy materials or provide patient perspectives

Stay Informed

Policy landscapes change rapidly. Stay current by:

• Following TMS-related news and research
• Monitoring state and federal policy developments
• Signing up for advocacy alerts from relevant organizations
• Attending professional conferences where policy issues are discussed

The Path Forward

The future of TMS coverage will likely involve:

Expanded Medicare coverage as the evidence base continues to grow

Standardized coverage criteria based on clinical evidence rather than insurer discretion

Increased competition as more device manufacturers enter the market

Alternative payment models that may improve access and reduce administrative burden

Telehealth integration making TMS more accessible in underserved areas

Getting Help Now

For patients who need TMS now, several resources may help:

• Manufacturer patient assistance programs — some TMS device companies offer financial support
• Clinic payment plans — many TMS providers offer installment payment options
• Clinical trials — research studies often provide free TMS treatment
• Flexible spending accounts (FSAs) and health savings accounts (HSAs) — these pre-tax dollars can be used for TMS

To get involved in TMS advocacy, contact the Clinical TMS Society (clinicaltmssociety.org) or National Alliance on Mental Illness (nami.org) for opportunities to make your voice heard.